Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Aptuit and Dimension Therapeutics have announced a strategic partnership agreement under which Aptuit will support GLP IND-enabling studies for select rare disease programs at Dimension. Three key integrated development projects have initiated under ...
read more
Tuesday, November 13, 2012
Aptuit LLC announced that the company has reached an agreement on a multiyear extension of its strategic partnership with GlaxoSmithKline (GSK) for dedicated drug development work at The Aptuit Center for Drug Discovery & Development in Verona, Italy...
read more
Wednesday, February 24, 2016
Aptuit and Icagen have announced a strategic alliance to give drug discovery customers access to ion channel and transporter technologies and expert services.
read more
Monday, December 07, 2015
Aptuit announced it has commenced a growth program for 2016 to meet significant increase in demand from customers in discovery, Chemistry, Manufacturing and Controls (CMC) and non-clinical development.
read more
Aptuit announced a strategic provider relationship between Aptuit and Regulus Therapeutics.
read more
Jonathan Goldman, CEO of Aptuit LLC, announced that Henning Steinhagen, PhD, has been named as President, Research and Development Operations. Henning will continue in his existing role of Site-Head at Aptuit, Verona, Italy whilst assuming oversight...
read more
Tuesday, January 24, 2017
Aptuit has announced the start of a collaboration with the Molecular Surgical Laboratory of Massachusetts General Hospital (MGH), directed by Dr. Laurence Rahme, aimed at the identification and validation of novel targets in Gram-negative bacteria. ...
read more
Thursday, October 13, 2016
Aptuit has relocated its recently acquired subsidiary Kuecept to its Oxford UK site, and added further formulation and safety assessment capacity to meet sustained customer demand for IND de-risking and enabling packages.
read more
Wednesday, November 30, 2016
Aptuit announced that it has successfully completed the expansion of their lead-like screening library. An additional 150,000 novel compounds have increased the Screening Collection to over 400,000.
read more
Friday, February 22, 2013
Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced that the company has formed the Aptuit Scientific Advisory Board (SAB) comprised of scientific experts from within the company. The SAB will regularly meet to assess ...
read more
Monday, November 12, 2012
Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced that the number of clients placing work at The Aptuit Center for Drug Discovery & Development in Verona, Italy has reached 100, giving the site a strong vote of confidence...
read more
Aptuit LLC announced that the company has innovated a translational strategy that represents a unique approach, known as “Complementary Vision,” for those in search of high value Chemistry, Manufacturing and Control (CMC) services.
read more
Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced that the company has launched an interactive link, “Ask an Expert,” on its website to provide informational support to the pharmaceutical community.
read more
Greenwich, CT, March 15, 2012 - Timothy C. Tyson, Aptuit Chairman, announced that effective immediately, Stuart E. Needleman has been named President and Chief Operating Officer of Aptuit LLC. Following the recent sale of the company’s Clinical ...
read more
Aptuit LLC announces the appointment of two new members to its Executive Leadership team. Kurt Dinkelacker has been named Executive Vice President and Chief Financial Officer and Kevin Duffield has been promoted to Vice President, Sales and Business ...
read more